S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
NASDAQ:RNLX

Renalytix AI News Headlines

$24.66
+2.55 (+11.53 %)
(As of 10/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$22.26
$24.99
50-Day Range
$17.91
$30.20
52-Week Range
$10.31
$35.71
Volume105,788 shs
Average Volume111,409 shs
Market Capitalization$890.60 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.33

Media Mentions By Week

Renalytix AI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RNLX
News Sentiment

-0.33

0.36

Average
Computer and Technology
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RNLX Articles
This Week

3

0

RNLX Articles
Average Week

Get Renalytix AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for RNLX and its competitors with MarketBeat's FREE daily newsletter.

Renalytix AI (NASDAQ RNLX) News Headlines Today

SourceHeadline
MarketBeat logoRenalytix AI (NASDAQ:RNLX) Trading Up 7.3%
americanbankingnews.com - October 15 at 1:04 PM
MarketBeat logoRenalytix AI (NASDAQ:RNLX) Shares Gap Up to $21.36
americanbankingnews.com - October 13 at 2:22 PM
MarketBeat logoRenalytix AI plc (NASDAQ:RNLX) Short Interest Up 20.7% in September
americanbankingnews.com - October 6 at 9:42 PM
MarketBeat logoRenalytix AI (NASDAQ:RNLX) Shares Gap Up to $20.51
americanbankingnews.com - October 6 at 12:30 PM
MarketBeat logoRenalytix AI (NASDAQ:RNLX) Earns Buy Rating from Analysts at Guggenheim
americanbankingnews.com - October 4 at 8:26 AM
MarketBeat logoRenalytix AI (NASDAQ:RNLX) Trading Up 7.1%
americanbankingnews.com - September 30 at 12:56 PM
finance.yahoo.com logoHedge Funds Are Piling Into Renalytix Plc (RNLX)
finance.yahoo.com - September 29 at 4:36 PM
MarketBeat logoRenalytix AI (NASDAQ:RNLX) Shares Gap Up to $19.12
americanbankingnews.com - September 29 at 11:06 AM
MarketBeat logo Analysts Anticipate Renalytix AI plc (NASDAQ:RNLX) Will Post Quarterly Sales of $1.01 Million
americanbankingnews.com - September 26 at 2:46 AM
MarketBeat logoZacks: Analysts Expect Renalytix AI plc (NASDAQ:RNLX) Will Post Quarterly Sales of $1.01 Million
americanbankingnews.com - September 26 at 2:46 AM
MarketBeat logo Brokerages Anticipate Renalytix AI plc (NASDAQ:RNLX) Will Post Earnings of -$0.18 Per Share
americanbankingnews.com - September 24 at 1:20 PM
MarketBeat logoRenalytix AI (NASDAQ:RNLX) Shares Gap Up to $18.25
americanbankingnews.com - September 22 at 12:38 PM
lse.co.uk logoRenalytix Plc Regulatory News
lse.co.uk - September 15 at 11:41 PM
au.finance.yahoo.com logoCentaur Labs Raises $15 Million, Led by Matrix Partners, to Label the World’s Medical Data, Accelerate AI Development
au.finance.yahoo.com - September 4 at 10:49 PM
sg.finance.yahoo.com logoAI Clearing Announces Strategic Global Partnership with Doosan Mobility Innovation
sg.finance.yahoo.com - August 27 at 8:31 PM
investorplace.com logoRenalytix Ai Plc ADR (RNLX)
investorplace.com - August 20 at 9:14 AM
finance.yahoo.com logo3 High-Growth Healthcare Stocks to Buy in August
finance.yahoo.com - August 3 at 7:54 AM
finance.yahoo.com logoRenalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory
finance.yahoo.com - July 22 at 9:42 AM
finance.yahoo.com logoRenalytix to Report Financial Results for Fiscal Third Quarter 2021 and Provide Corporate Update
finance.yahoo.com - June 10 at 9:23 AM
finance.yahoo.com logoUtility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care
finance.yahoo.com - June 3 at 10:02 AM
finance.yahoo.com logoKantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order
finance.yahoo.com - June 2 at 1:13 PM
finance.yahoo.com logoAtrium Health, Wake Forest Baptist Health, Wake Forest School of Medicine and Renalytix Partner to Advance Kidney Health
finance.yahoo.com - May 19 at 8:07 AM
au.finance.yahoo.com logoRenalytix AI plc (RTNXF)
au.finance.yahoo.com - May 13 at 10:33 PM
finance.yahoo.com logoKantaro's COVID-SeroKlir Antibody Test Named As A Finalist For Fast Company's 2021 World Changing Ideas Awards
finance.yahoo.com - May 4 at 6:22 PM
nasdaq.com logoStock Alert: Renalytix Gains 17% On Winning Multi-year Contract
nasdaq.com - April 22 at 11:26 AM
finance.yahoo.com logoU.S. General Services Administration Grants 10-Year Governmentwide Contract for RenalytixAI KidneyIntelX Testing
finance.yahoo.com - April 22 at 11:26 AM
ca.finance.yahoo.com logoKidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS)
ca.finance.yahoo.com - April 20 at 10:14 AM
finance.yahoo.com logoRenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platform
finance.yahoo.com - April 14 at 11:15 AM
finance.yahoo.com logoClinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions
finance.yahoo.com - April 8 at 7:25 AM
finance.yahoo.com logoMulti-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure
finance.yahoo.com - April 5 at 9:19 AM
finance.yahoo.com logoUpdate on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics
finance.yahoo.com - March 15 at 9:50 AM
finance.yahoo.com logoRenalytix AI plc Issue of Shares Under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights
finance.yahoo.com - March 4 at 4:11 PM
benzinga.com logoRenalytix AI plc Issue of Shares Under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights
benzinga.com - March 4 at 1:43 PM
finance.yahoo.com logoRenalytix AI Plc - ADR to Host Earnings Call
finance.yahoo.com - March 2 at 7:09 AM
finance.yahoo.com logoRenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021
finance.yahoo.com - March 2 at 7:09 AM
finance.yahoo.com logoThe University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health
finance.yahoo.com - February 24 at 8:09 AM
seekingalpha.com logoRenalytix AI: Time To Grow Into Its Valuation
seekingalpha.com - February 12 at 5:38 PM
finance.yahoo.com logoFDA Adds Kantaro's Semi-Quantitative COVID-19 Antibody Test to Revised Emergency Use Authorization for Convalescent Plasma
finance.yahoo.com - February 10 at 11:45 AM
finance.yahoo.com logoRenalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics
finance.yahoo.com - January 13 at 2:49 AM
finance.yahoo.com logoRenalytix AI (RNLX) Catches Eye: Stock Jumps 7%
finance.yahoo.com - January 6 at 12:37 PM
seekingalpha.com logoRenalytixAI soars 20% as FDA OK's emergency use of Kantaro's COVID-19 antibody test
seekingalpha.com - November 27 at 12:56 AM
seekingalpha.com logoRenalytix AI EPS misses by $0.04
seekingalpha.com - November 25 at 7:55 AM
finance.yahoo.com logoKantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies
finance.yahoo.com - November 25 at 7:55 AM
benzinga.com logoRenalytixAI to Participate in the Stifel 2020 Healthcare Conference
benzinga.com - November 13 at 3:20 AM
Get Renalytix AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for RNLX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.